1,3-dipropylxanthine has been researched along with kf 17837 in 1 studies
Studies (1,3-dipropylxanthine) | Trials (1,3-dipropylxanthine) | Recent Studies (post-2010) (1,3-dipropylxanthine) | Studies (kf 17837) | Trials (kf 17837) | Recent Studies (post-2010) (kf 17837) |
---|---|---|---|---|---|
26 | 0 | 0 | 8 | 0 | 0 |
Protein | Taxonomy | 1,3-dipropylxanthine (IC50) | kf 17837 (IC50) |
---|---|---|---|
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.062 | |
Adenosine receptor A2a | Homo sapiens (human) | 0.001 | |
Adenosine receptor A2b | Homo sapiens (human) | 1.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichikawa, S; Ishii, A; Nonaka, H; Shimada, J; Suzuki, F | 1 |
1 other study(ies) available for 1,3-dipropylxanthine and kf 17837
Article | Year |
---|---|
(E)-1,3-dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cell Membrane; Corpus Striatum; Guinea Pigs; Molecular Structure; Prosencephalon; Purinergic Antagonists; Rats; Structure-Activity Relationship; Xanthines | 1992 |